We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

An efficient method for generation of neural-like cells from adult human bone marrow-derived mesenchymal stem cells

    Arshak R Alexanian

    Neuroscience Research Laboratories, Department of Neurosurgery, VA Medical Center – Research 151, 5000 West National Avenue, Milwaukee, Wisconsin, WI 53295, USA.

    Published Online:https://doi.org/10.2217/rme.10.67

    Background: Stem cell-based therapies to repair and replace lost neural cells are a highly promising treatment for CNS diseases. Bone marrow (BM)-derived mesenchymal stem cells (MSCs) have great potential as therapeutic agents against neurological maladies, since they have the ability to differentiate into neural phenotypes and can be readily isolated and expanded for autotransplantation with no risk of rejection. In our previous studies, we demonstrated that neural cells could be efficiently generated from mouse BM-derived MSCs by exposing cells to epigenetic modifiers and a neural environment. The main idea of this approach was the reactivation of pluripotency-associated genes in MSCs before exposing them to neural-inducing factors. Aim: In this study, we used a similar approach to efficiently generate neural cells from human BM-derived MSCs. Method: Neural induction was achieved by exposing cells simultaneously to inhibitors of DNA methylation and histone deacetylation, and pharmacological agents that increase cAMP levels. Results: The expression of pluripotency and neural markers was confirmed with immunocytochemistry, western blot and real-time PCR. ELISA studies showed that these neurally induced-human MSCs cells released the neurotrophic factors glial cell-derived neurotrophic factor and brain-derived neurotrophic factor. Conclusion: Human MSCs that are neurally modified with this methodology could be a useful source of cells for CNS repair and regeneration.

    Bibliography

    • Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126(4),663–676 (2006).
    • Kim D, Kim CH, Moon JI et al.: Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell4(6),472–476 (2009).
    • Kunisato A, Wakatsuki M, Kodama Y et al.: Generation of induced pluripotent stem (iPS) cells by efficient reprogramming of adult bone marrow cells. Stem Cells Dev.19(2),229–238 (2009).
    • Ohnuki M, Takahashi K, Yamanaka S: Generation and characterization of human induced pluripotent stem cells. Curr. Protoc. Stem Cell Biol.4, Unit 4A.2 (2009).
    • Lyssiotis CA, Walker J, Wu C et al.: Inhibition of histone deacetylase activity induces developmental plasticity in oligodendrocyte precursor cells. Proc. Natl Acad. Sci. USA104(38),14982–14987 (2007).
    • Prockop DJ: Marrow stromal cells as stem cells for nonhematopoietic tissues. Science276(5309),71–74 (1997).
    • Kuznetsov SA, Mankani MH, Gronthos S et al.: Circulating skeletal stem cells. J. Cell Biol.153(5),1133–1140 (2001).
    • Lee JY, Qu-Petersen Z, Cao B et al.: Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J. Cell Biol.150(5),1085–1100 (2000).
    • Brighton CT, Lorich DG, Kupcha R et al.: The pericyte as a possible osteoblast progenitor cell. Clin. Orthop.(275),287–299 (1992).
    • 10  Mizuno S, Glowacki J: Chondroinduction of human dermal fibroblasts by demineralized bone in three-dimensional culture. Exp. Cell Res.227(1),89–97 (1996).
    • 11  Zuk PA, Zhu M, Mizuno H et al.: Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng.7(2),211–228 (2001).
    • 12  Lee OK, Kuo TK, Chen WM et al.: Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood103(5),1669–1675 (2004).
    • 13  Pereira RF, Halford KW, O’Hara MD et al.: Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc. Natl Acad. Sci. USA92(11),4857–4861 (1995).
    • 14  Pereira RF, O’Hara MD, Laptev AV et al.: Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc. Natl Acad. Sci. USA95(3),1142–1147 (1998).
    • 15  Umezawa A, Tachibana K, Harigaya K et al.: Colony-stimulating factor 1 expression is down-regulated during the adipocyte differentiation of H-1/A marrow stromal cells and induced by cachectin/tumor necrosis factor. Mol. Cell Biol.11(2),920–927 (1991).
    • 16  Ferrari G, Cusella-De Angelis G, Coletta M et al.: Muscle regeneration by bone marrow-derived myogenic progenitors. Science279(5356),1528–1530 (1998).
    • 17  Makino S, Fukuda K, Miyoshi S et al.: Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest.103(5),697–705 (1999).
    • 18  Kohyama J, Abe H, Shimazaki T et al.: Brain from bone: efficient ‘meta-differentiation’ of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent. Differentiation68(4–5),235–244 (2001).
    • 19  Azizi SA, Stokes D, Augelli BJ, DiGirolamo C, Prockop DJ: Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats – similarities to astrocyte grafts. Proc. Natl Acad. Sci. USA95(7),3908–3913 (1998).
    • 20  Kopen GC, Prockop DJ, Phinney DG: Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc. Natl Acad. Sci. USA96(19),10711–10716 (1999).
    • 21  Munoz-Elias G, Marcus AJ, Coyne TM, Woodbury D, Black IB: Adult bone marrow stromal cells in the embryonic brain: engraftment, migration, differentiation, and long-term survival. J. Neurosci.24(19),4585–4595 (2004).
    • 22  Kim SS, Choi JM, Kim JW et al.: cAMP induces neuronal differentiation of mesenchymal stem cells via activation of extracellular signal-regulated kinase/MAPK. Neuroreport16(12),1357–1361 (2005).
    • 23  Sanchez-Ramos J, Song S, Cardozo-Pelaez F et al.: Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp. Neurol.164(2),247–256 (2000).
    • 24  Kim BJ, Seo JH, Bubien JK, Oh YS: Differentiation of adult bone marrow stem cells into neuroprogenitor cells in vitro. Neuroreport13(9),1185–1188 (2002).
    • 25  Joannides A, Gaughwin P, Scott M et al.: Postnatal astrocytes promote neural induction from adult human bone marrow-derived stem cells. J. Hematother. Stem Cell Res.12(6),681–688 (2003).
    • 26  Padovan CS, Jahn K, Birnbaum T et al.: Expression of neuronal markers in differentiated marrow stromal cells and CD133+ stem-like cells. Cell Transplant.12(8),839–848 (2003).
    • 27  Kondo T, Johnson SA, Yoder MC, Romand R, Hashino E: Sonic hedgehog and retinoic acid synergistically promote sensory fate specification from bone marrow-derived pluripotent stem cells. Proc. Natl Acad. Sci. USA102(13),4789–4794 (2005).
    • 28  Chen Q, Long Y, Yuan X et al.: Protective effects of bone marrow stromal cell transplantation in injured rodent brain: synthesis of neurotrophic factors. J. Neurosci. Res.80(5),611–619 (2005).
    • 29  Long X, Olszewski M, Huang W, Kletzel M: Neural cell differentiation in vitro from adult human bone marrow mesenchymal stem cells. Stem Cells Dev.14(1),65–69 (2005).
    • 30  Lu P, Blesch A, Tuszynski MH: Induction of bone marrow stromal cells to neurons: differentiation, transdifferentiation, or artifact? J. Neurosci. Res.77(2),174–191 (2004).
    • 31  Yang XS, Wu HX, Xiao B: [Human mesenchymal stem cells differentiate into neuron-like cells and show SMN protein expression]. Zhonghua Yi Xue Za Zhi85(16),1125–1128 (2005).
    • 32  Munoz-Elias G, Woodbury D, Black IB: Marrow stromal cells, mitosis, and neuronal differentiation: stem cell and precursor functions. Stem Cells21(4),437–448 (2003).
    • 33  Deng W, Obrocka M, Fischer I, Prockop DJ: In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochem. Biophys. Res. Commun.282(1),148–152 (2001).
    • 34  Hermann A, Liebau S, Gastl R et al.: Comparative analysis of neuroectodermal differentiation capacity of human bone marrow stromal cells using various conversion protocols. J. Neurosci. Res.83(8),1502–1514 (2006).
    • 35  Episkopou V: SOX2 functions in adult neural stem cells. Trends Neurosci.28(5),219–221 (2005).
    • 36  Ankeny DP, McTigue DM, Jakeman LB: Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats. Exp. Neurol.190(1),17–31 (2004).
    • 37  Jori FP, Napolitano MA, Melone MA et al.: Molecular pathways involved in neural in vitro differentiation of marrow stromal stem cells. J. Cell Biochem.94(4),645–655 (2005).
    • 38  Dezawa M, Kanno H, Hoshino M et al.: Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J. Clin. Invest.113(12),1701–1710 (2004).
    • 39  Qian L, Saltzman WM: Improving the expansion and neuronal differentiation of mesenchymal stem cells through culture surface modification. Biomaterials25(7–8),1331–1337 (2004).
    • 40  Jiang Y, Henderson D, Blackstad M et al.: Neuroectodermal differentiation from mouse multipotent adult progenitor cells. Proc. Natl Acad. Sci. USA100(Suppl. 1),11854–11860 (2003).
    • 41  Wislet-Gendebien S, Hans G, Leprince P et al.: Plasticity of cultured mesenchymal stem cells: switch from nestin-positive to excitable neuron-like phenotype. Stem Cells23(3),392–402 (2005).
    • 42  Alexanian AR: Neural stem cells induce bone-marrow-derived mesenchymal stem cells to generate neural stem-like cells via juxtacrine and paracrine interactions. Exp. Cell Res.310(2),383–391 (2005).
    • 43  Krampera M, Marconi S, Pasini A et al.: Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus. Bone40(2),382–390 (2007).
    • 44  Shiota M, Heike T, Haruyama M et al.: Isolation and characterization of bone marrow-derived mesenchymal progenitor cells with myogenic and neuronal properties. Exp. Cell Res.313(5),1008–1023 (2007).
    • 45  Qu TY, Dong XJ, Sugaya I et al.: Bromodeoxyuridine increases multipotency of human bone marrow-derived stem cells. Restor. Neurol. Neurosci.22(6),459–468 (2004).
    • 46  Terada N, Hamazaki T, Oka M et al.: Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature416(6880),542–545 (2002).
    • 47  Neuhuber B, Gallo G, Howard L et al.: Reevaluation of in vitro differentiation protocols for bone marrow stromal cells: disruption of actin cytoskeleton induces rapid morphological changes and mimics neuronal phenotype. J. Neurosci. Res.77(2),192–204 (2004).
    • 48  Mareschi K, Rustichelli D, Comunanza V et al.: Multipotent mesenchymal stem cells from amniotic fluid originate neural precursors with functional voltage-gated sodium channels. Cytotherapy11(5),534–547 (2009).
    • 49  Bonilla S, Silva A, Valdes L et al.: Functional neural stem cells derived from adult bone marrow. Neuroscience133(1),85–95 (2005).
    • 50  Kim SS, Yoo SW, Park TS et al.: Neural induction with neurogenin1 increases the therapeutic effects of mesenchymal stem cells in the ischemic brain. Stem Cells26(9),2217–2228 (2008).
    • 51  Trzaska KA, King CC, Li KY et al.: Brain-derived neurotrophic factor facilitates maturation of mesenchymal stem cell-derived dopamine progenitors to functional neurons. J. Neurochem.110(3),1058–1069 (2009).
    • 52  Alexanian AR, Maiman DJ, Kurpad SN, Gennarelli TA: In vitro and in vivo characterization of neurally modified mesenchymal stem cells induced by epigenetic modifiers and neural stem cell environment. Stem Cells Dev.17(6),1123–1130 (2008).
    • 53  Hermann A, Gastl R, Liebau S et al.: Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells. J. Cell Sci.117(Pt 19),4411–4422 (2004).
    • 54  Alexanian AR: Epigenetic modifiers promote efficient generation of neural-like cells from bone marrow-derived mesenchymal cells grown in neural environment. J. Cell Biochem.100(2),362–371 (2007).
    • 55  Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA76(9),4350–4354 (1979).
    • 56  Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-DD CT method. Methods25(4),402–408 (2001).
    • 57  Okita K, Ichisaka T, Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature448(7151),313–317 (2007).
    • 58  Yu J, Vodyanik MA, Smuga-Otto K et al.: Induced pluripotent stem cell lines derived from human somatic cells. Science318(5858),1917–1920 (2007).
    • 59  Takahashi K, Tanabe K, Ohnuki M et al.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell131(5),861–872 (2007).
    • 60  Eggenschwiler R, Cantz T: Induced pluripotent stem cells generated without viral integration. Hepatology49(3),1048–1049 (2009).
    • 61  Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S: Generation of mouse induced pluripotent stem cells without viral vectors. Science322(5903),949–953 (2008).
    • 62  Zhou H, Wu S, Joo JY et al.: Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell4(5),381–384 (2009).
    • 63  Kim JB, Zaehres H, Wu G et al.: Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature454(7204),646–650 (2008).
    • 64  Page RL, Ambady S, Holmes WF et al.: Induction of stem cell gene expression in adult human fibroblasts without transgenes. Cloning Stem Cells11(3),417–426 (2009).
    • 65  Schmittwolf C, Kirchhof N, Jauch A et al.: In vivo haematopoietic activity is induced in neurosphere cells by chromatin-modifying agents. EMBO J.24(3),554–566 (2005).
    • 66  Ruau D, Ensenat-Waser R, Dinger TC et al.: Pluripotency associated genes are reactivated by chromatin-modifying agents in neurosphere cells. Stem Cells26(4),920–926 (2008).
    • 67  Rooney GE, Howard L, O’Brien T, Windebank AJ, Barry FP: Elevation of cAMP in mesenchymal stem cells transiently upregulates neural markers rather than inducing neural differentiation. Stem Cells Dev.18(3),387–398 (2009).